Acrivon Therapeutics Appoints Michaela Levin, Ph.D., as Chief Business Officer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/31/2026

1. NVDA
2. PCG
3. AMZN
4. AAPL
5. AVGO
6. EC
7. ALNY
8. CNS
9. STLA
10. SPCX

Go back to Acrivon Therapeutics Appoints Michaela Levin, Ph.D., as Chief Business Officer
(NASDAQ: ACRV) Delayed: 2.09 +0.03 (1.46%)
Previous Close $2.06    52 Week High $ 
Open $2.04    52 Week Low $ 
Day High $2.11    P/E N/A 
Day Low $2.02    EPS $ 
Volume 160,127